Accepted at 7:01 p.m. Jul, 02, 2025 by Ahmed7
Author: jollydolphin
Related Note: 1473995720927
Rationale for change

Match noteid 1488765231664 by using the γ character here too.

Text Text
Extra
Lecture Notes
Empty field
Missed Questions
Empty field
Pathoma
Empty field
Boards and Beyond
Empty field
First Aid
Sketchy
Sketchy 2
Sketchy Extra
Empty field
Picmonic
Empty field
Pixorize
Physeo
Bootcamp
OME
Additional Resources
One by one
Empty field
#AK_Step1_v12::#Physeo::05_Biochem::05_Metabolism::41_Vitamin_K_-_Nutrition #AK_Step2_v12::#B&B::07_Hematology_and_Oncology::02_Coagulation::05_Anticoagulants #AK_Step1_v12::#FirstAid::10_Hematology_and_Oncology::03_Physiology::06_Vitamin_K-dependent_coagulation::*Vitamin_K-Dependent_Coagulation_Components #AK_Step1_v12::#NBME::31 #AK_Step2_v12::#FirstAid::07_Hematology::01_Coagulation_Disorders::01_Normal_Hemostasis #AK_Step2_v12::#UWorld::Step::4187 #AK_Step2_v12::#AMBOSS::tx0XyR #AK_Step1_v12::#SketchyPath::09_Blood_&_Coagulation::03_Coagulopathies_&_Platelet_Disorders::04_Acquired_Coagulation_Defects #AK_Step2_v12::#AMBOSS::RC0l7R #AK_Step1_v12::#NinjaNerd::06_Cardiovascular::04_Pharmacology::02_Warfarin_(MOA,_Indications,_AR,_CI) #AK_Step1_v12::#Physeo::^physeo_image_update #AK_Step2_v12::#SketchyIM::08_Hematology_&_Oncology::01_Bleeding_&_Clotting_Disorders::01_Bleeding_Disorders:_Coagulation_Factor_Disorders_DDx #AK_Step1_v12::#AMBOSS::Rialr4 #AK_Step1_v12::#Pixorize::01_Biochemistry::01_Vitamins::20_Vitamin_K_Biochemistry #AK_Step2_v12::#AMBOSS::xx0EAR #AK_Other::AnKing_Image::Aiman::Coagulation_Cascade #AK_Step1_v12::#SketchyBiochem::04_Vitamins/Minerals::02_Fat_Soluble::04_Vitamin_K #AK_Step1_v12::#UWorld::COMLEX::108332 #AK_Step1_v12::#B&B::12_Hematology::01_Hemostasis::07_Anticoagulant_Drugs #AK_Other::AnKing_Image::!Subjects::Hematology::Coagulation_Cascade #AK_Step1_v12::#UWorld::COMLEX::24173 #AK_Step1_v12::#B&B::04_Biochem::04_Vitamins::03_Other_Vitamins #AK_Step1_v12::#UWorld::Step::1062 #AK_Other::#AK_Original_Decks::Step_1::Zanki_Step_Decks::Zanki_Hematology_&_Oncology::Pathoma_Hematology #AK_Step1_v12::#B&B::12_Hematology::01_Hemostasis::03_Hypercoagulable_States::Extra #AK_Step2_v12::#UWorld::Step::3089 #AK_Step1_v12::#SketchyPharm::03_Blood_&_Inflammation::01_Anticoagulants_&_Thrombolytics::02_Warfarin #AK_Step1_v12::#AMBOSS::M5aMkO #AK_Step1_v12::#AMBOSS::Xz09ri #AK_Step1_v12::#SketchyPhysiology::10_Hematology::01_Blood_Components_&_Function::01_Coagulation_Cascade #AK_Step1_v12::^Systems::HemeOnc::Hematology #AK_Step1_v12::#Pixorize::03_Pharmacology::11_Heme_Pharm::01_Warfarin #AK_Step2_v12::#UWorld::COMLEX::28896 #AK_Step1_v12::#NinjaNerd::09_Hematology::02_Pathology::18_Coagulopathy #AK_Other::AnKing_Image::Aiman #AK_Step1_v12::#AMBOSS::_ja51k #AK_Other::Only_Step_1 #AK_Step1_v12::#Pixorize::01_Biochemistry::01_Vitamins::21_Vitamin_K_Deficiency #AK_Step1_v12::#NinjaNerd::09_Hematology::02_Pathology::15_Antiplatelets,_Anticoagulants,_and_Thrombolytics #AK_Step1_v12::#OME::Clinical::Internal_Medicine::Hematology-Oncology::Approach_To_Bleeding #AK_Step1_v12::#UWorld::COMLEX::27361 #AK_Step1_v12::#UWorld::Step::106673 #AK_Step1_v12::#UWorld::Step::20361 #AK_Step2_v12::#AMBOSS::Rialr4 #AK_Step1_v12::#Pathoma::04_Hemostasis::02_Secondary_Hemostasis_&_Related_Disorders #AK_Step1_v12::#Bootcamp::Hematology_and_Oncology::07_Coagulation_and_Fibrinolysis::02_Bleeding_Time,_Prothrombin_Time,_INR,_and_Partial_Thromboplastin_Time #AK_Step1_v12::#Bootcamp::Biochemistry::12_Vitamins::05_Vitamin_K_Vitamin_K_Cycle #AK_Step1_v12::#NBME::33 #AK_Step1_v12::#B&B::12_Hematology::01_Hemostasis::01_Coagulation #AK_Step1_v12::#FirstAid::10_Hematology_and_Oncology::04_Pathology::16_Coagulation_disorders::*Vitamin_K_Deficiency #AK_Step1_v12::#Low/HighYield::1-HighYield #AK_Step1_v12::#FirstAid::01_Biochem::05_Nutrition::17_Vitamin_K::02_Deficiency #AK_Step1_v12::#Bootcamp::Hematology_and_Oncology::07_Coagulation_and_Fibrinolysis::09_Vitamin_K_Dependent_Coagulation_Factors